IN2013MU01226A - - Google Patents
Info
- Publication number
- IN2013MU01226A IN2013MU01226A IN1226MU2013A IN2013MU01226A IN 2013MU01226 A IN2013MU01226 A IN 2013MU01226A IN 1226MU2013 A IN1226MU2013 A IN 1226MU2013A IN 2013MU01226 A IN2013MU01226 A IN 2013MU01226A
- Authority
- IN
- India
- Prior art keywords
- regadenoson
- amorphous
- provides
- stable
- preparation
- Prior art date
Links
- LZPZPHGJDAGEJZ-AKAIJSEGSA-N regadenoson Chemical compound C1=C(C(=O)NC)C=NN1C1=NC(N)=C(N=CN2[C@H]3[C@@H]([C@H](O)[C@@H](CO)O3)O)C2=N1 LZPZPHGJDAGEJZ-AKAIJSEGSA-N 0.000 abstract 2
- 229960003614 regadenoson Drugs 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1226MU2013 IN2013MU01226A (h) | 2013-03-28 | 2013-03-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1226MU2013 IN2013MU01226A (h) | 2013-03-28 | 2013-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01226A true IN2013MU01226A (h) | 2015-04-17 |
Family
ID=54395600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1226MU2013 IN2013MU01226A (h) | 2013-03-28 | 2013-03-28 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01226A (h) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
-
2013
- 2013-03-28 IN IN1226MU2013 patent/IN2013MU01226A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
| US11034714B2 (en) | 2015-02-06 | 2021-06-15 | Apicore Us Llc | Process of making regadenoson and novel polymorphs thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| MX370611B (es) | Metodos utiles en la sintesis de analogos de halicondrina b. | |
| EP3082817A4 (en) | Compositions for drug administration | |
| IL243627A (en) | High-power pancreatic pharmaceuticals | |
| IL274583B (en) | Pharmaceutical preparations of pancreatin with high potency | |
| IN2013MU00711A (h) | ||
| IN2013MU03641A (h) | ||
| MX2017001487A (es) | Sofosbuvir en forma cristalina y proceso para su preparacion. | |
| MX2016015464A (es) | Composicion farmaceutica oral de isotretinoina. | |
| EP3020417A4 (en) | Pharmaceutical composition for respiratory administration | |
| HUP1300647A2 (hu) | Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik | |
| IN2013MU01985A (h) | ||
| IN2013MU01111A (h) | ||
| IL245260A0 (en) | Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof | |
| IN2013CH04314A (h) | ||
| IN2013MU01226A (h) | ||
| IN2013MU03565A (h) | ||
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| IN2013MU01160A (h) | ||
| WO2014147464A3 (en) | Novel process for the preparation of tolcapone | |
| IN2014CH01391A (h) | ||
| MX355103B (es) | Composicion para el tratamiento de desordenes inflamatorios e inmunes. | |
| IN2013MU03656A (h) | ||
| IN2013MU03310A (h) | ||
| WO2014108921A3 (en) | Carvedilol phosphate solid dispersion |